E. Daudén

10.8k total citations
267 papers, 5.4k citations indexed

About

E. Daudén is a scholar working on Immunology, Dermatology and Rheumatology. According to data from OpenAlex, E. Daudén has authored 267 papers receiving a total of 5.4k indexed citations (citations by other indexed papers that have themselves been cited), including 165 papers in Immunology, 95 papers in Dermatology and 53 papers in Rheumatology. Recurrent topics in E. Daudén's work include Psoriasis: Treatment and Pathogenesis (154 papers), Dermatology and Skin Diseases (63 papers) and Health Systems, Economic Evaluations, Quality of Life (32 papers). E. Daudén is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (154 papers), Dermatology and Skin Diseases (63 papers) and Health Systems, Economic Evaluations, Quality of Life (32 papers). E. Daudén collaborates with scholars based in Spain, Germany and Italy. E. Daudén's co-authors include L. Puig, Amaro García‐Diez, Francisco Abad‐Santos, J.L. Sánchez‐Carazo, J.M. Carrascosa, Teresa Cabaleiro, F. Vanaclocha, Rocío Prieto‐Pérez, Manuel Román and Silvia González‐Parra and has published in prestigious journals such as SHILAP Revista de lepidopterología, Nature Immunology and Scientific Reports.

In The Last Decade

E. Daudén

254 papers receiving 5.3k citations

Peers

Countries citing papers authored by E. Daudén

Since Specialization

Citations

This map shows the geographic impact of E. Daudén's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Daudén with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Daudén more than expected).

Fields of papers citing papers by E. Daudén

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Daudén. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Daudén. The network helps show where E. Daudén may publish in the future.

Co-authorship network of co-authors of E. Daudén

This figure shows the co-authorship network connecting the top 25 collaborators of E. Daudén. A scholar is included among the top collaborators of E. Daudén based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Daudén. E. Daudén is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Secukinumab for Treatment of Plaque Psoriasis in Real-World Clinical Practice in Spain: A Literature Review 2025 ·Journal of Clinical Medicine ·E. Daudén, José María Ortiz Salvador, J. Notario, L. Puig, Jorge Santos‐Juanes, Enrique Herrera‐Acosta, (unknown), Ricardo Ruíz‐Villaverde	2
2	Ten-Year Persistence of Biologic Drugs in Psoriasis and Its Relationship with Pharmacogenetic Biomarkers 2024 ·Biomedicines ·(unknown), (unknown), Rocío Prieto‐Pérez, (unknown), (unknown), (unknown), (unknown), E. Daudén, Francisco Abad‐Santos	0
3	Implementing well‐being in the management of psoriasis: An expert recommendation 2023 ·Journal of the European Academy of Dermatology and Venereology ·Rachel Sommer, Ulrich Mrowietz, Kristian Gaarn du Jardin, Ismail Kasujee, Elisa Martini, E. Daudén, Gabriella Fabbrocini, Alexander Zink, C.E.M. Griffiths, Matthias Augustin	7
4	Patient-reported well-being in value-based care using tildrakizumab in a real-world setting: protocol of a multinational, phase IV, 1-cohort prospective observational study (the POSITIVE study) 2023 ·BMJ Open ·Matthias Augustin, Rachel Sommer, E. Daudén, Philip Laws, E.M.G.J. de Jong, Gabriella Fabbrocini, Luigi Naldi, Alexander A. Navarini, Jo Lambert, Z. Reguiaï, Sascha Gerdes, (unknown), Teresa Obis, Ismail Kasujee, Ulrich Mrowietz	8
5	Persistence and effectiveness of guselkumab treatment in patients with moderate‐to‐severe plaque psoriasis in a non‐interventional real‐world setting: The SPRING study 2023 ·Journal of the European Academy of Dermatology and Venereology ·L. Puig, E. Daudén, (unknown), (unknown), (unknown)	3
6	The DERMACLEAR study: Verification results of a natural language processing system in dermatology 2023 ·SHILAP Revista de lepidopterología ·F.J. Ortiz de Frutos, Ana M. Giménez‐Arnau, L. Puig, J.F. Silvestre, (unknown), L. Salgado‐Boquete, Vicente García‐Patos, J.L. López‐Estebaranz, J. Notario, A. Martín‐Santiago, (unknown), Victor Martín, (unknown), (unknown), E. Daudén	1
7	Cutaneous vascular calcification. Perieccrine calcification as a diagnostic key for calciphylaxis 2022 ·Journal of Cutaneous Pathology ·Alejandra Reolid, (unknown), Pedro Rodríguez‐Jiménez, (unknown), Mar Llamas‐Velasco, Javier Fraga, E. Daudén	0
8	Tildrakizumab efficacy and safety in patients with psoriasis and concomitant metabolic syndrome: post hoc analysis of 5‐year data from reSURFACE 1 and reSURFACE 2 2022 ·Journal of the European Academy of Dermatology and Venereology ·Anthony P. Fernandez, E. Daudén, Sascha Gerdes, Mark Lebwohl, Alan Menter, C. Leonardi, Melinda Gooderham, Kurt Gebauer, Yayoi Tada, J.‐P. Lacour, Luca Bianchi, Alexander Egeberg, Ignasi Pau‐Charles, Alan M. Mendelsohn, Stephen J. Rozzo, Nehal N. Mehta	15
9	Methylation in psoriasis. Does sex matter? 2020 ·Journal of the European Academy of Dermatology and Venereology ·Mar Llamas‐Velasco, Alejandra Reolid, Ancor Sanz‐García, Lola Alonso, Jorge García–Martínez, (unknown), (unknown), E. Daudén, Francisco Abad‐Santos, María C. Ovejero‐Benito	3
10	Poroqueratosis pruriginosa diseminada inflamatoria. Buena respuesta a ciclosporina 2015 ·Actas Dermo-Sifiliográficas ·(unknown), (unknown), D. de Argila, (unknown), E. Daudén	3
11	Development and Validation of a New Instrument to Measure Health-related Quality of Life in Patients with Psoriatic Arthritis: The VITACORA-19 2014 ·The Journal of Rheumatology ·Juan Carlos Torre‐Alonso, Jordi Gratacós, (unknown), (unknown), (unknown), E. Daudén, Mireia Moreno, Pedro Zarco, Eduardo Collantes‐Estévez, Juan Antonio Fernández-López	14
12	Lupus eritematoso subagudo inducido por terbinafina en un paciente con lupus eritematoso sistémico 2014 ·Revista Clínica Española ·(unknown), G. Solano‐López, Concepción García García, Rosario García‐Vicuña, E. Daudén	1
13	Association between psoriasis and polymorphisms in the TNF, IL12B, and IL23R genes in Spanish patients 2013 ·European Journal of Dermatology ·Teresa Cabaleiro, Manuel Román, Elena Gallo, Dolores Ochoa, (unknown), María Talegón, Rocío Prieto‐Pérez, Amaro García‐Diez, E. Daudén, Francisco Abad‐Santos	19
14	Mental Health Self-Assessment in Patients With Moderate to Severe Psoriasis: An Observational, Multicenter Study of 1164 Patients in Spain (The VACAP Study) 2013 ·Actas Dermo-Sifiliográficas ·Ramón M. Pujol, L. Puig, E. Daudén, J.L. Sánchez‐Carazo, J. Toribio, F. Vanaclocha, Mireia Yébenes, (unknown), Miguel Á. Casado, M.T. Caloto, (unknown)	23
15	Latent tuberculosis infection and active tuberculosis in patients with psoriasis: a study on the incidence of tuberculosis and the prevalence of latent tuberculosis disease in patients with moderate–severe psoriasis in Spain. BIOBADADERM registry 2012 ·Journal of the European Academy of Dermatology and Venereology ·(unknown), I. García‐Doval, G. Carretero, José Luis Sánchez‐Carazo, (unknown), (unknown), M. Alsina, Marta Ferrán, J.L. López‐Estebaranz, Francisco Gómez‐García, P. de la Cueva Dobao, J.M. Carrascosa, F. Vanaclocha, I. Belinchón, (unknown), E. Daudén, (unknown)	37
16	Effectiveness and satisfaction with imiquimod for the treatment of superficial basal cell carcinoma in daily dermatological practice 2011 ·Journal of the European Academy of Dermatology and Venereology ·E. Daudén, (unknown)	14
17	Percepción del médico y paciente de la gravedad de la psoriasis, su impacto en la calidad de vida y satisfacción con la atención y el tratamiento recibido. Estudio observacional en España 2011 ·Actas Dermo-Sifiliográficas ·E. Daudén, (unknown), (unknown)	12
18	Treatment and Management of Psoriasis with Nail Involvement: A Focus on Biologic Therapy 2010 ·Dermatology ·Richard G. Langley, E. Daudén	45
19	Improvements in patient-reported outcomes in moderate-to-severe psoriasis patients receiving continuous or paused etanercept treatment over 54 weeks: the CRYSTEL study 2009 ·Journal of the European Academy of Dermatology and Venereology ·E. Daudén, C.E.M. Griffiths, Ortonne Jp, Knud Kragballe, (unknown), Deborah Robertson, Ronald Pedersen, (unknown), (unknown)	84
20	Recommendations for the use of etanercept in psoriasis: a European dermatology expert group consensus 2006 ·Journal of the European Academy of Dermatology and Venereology ·Wolf‐Henning Boehncke, (unknown), Juliet N. Barker, Sergio Chimenti, E. Daudén, Menno A. de Rie, Louis Dubertret, Alberto Giannetti, Andreas Katsambas, Knud Kragballe, J.M. Naeyaert, Ortonne Jp, Jordi Peyrı́, JC Prinz, (unknown), Robert Strohal, P.C.M. van de Kerkhof, Wolfram Sterry	31

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact